Cargando…
Fumaric acid esters in the management of psoriasis
Fumaric acid esters (FAE) are small molecules with immunomodulating, anti-inflammatory, and anti-oxidative effects. FAE were introduced as a systemic psoriasis treatment in 1959 and empirically developed further between 1970 and 1990 in Germany, Switzerland, and the Netherlands. The development of F...
Autor principal: | Balak, Deepak MW |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683116/ https://www.ncbi.nlm.nih.gov/pubmed/29387578 http://dx.doi.org/10.2147/PTT.S51490 |
Ejemplares similares
-
Treatment of lupus erythematosus with fumaric acid ester derivatives: two case-reports
por: Balak, Deepak MW, et al.
Publicado: (2011) -
Drug-induced Fanconi syndrome associated with fumaric acid esters treatment for psoriasis: a case series
por: Balak, Deepak M.W., et al.
Publicado: (2016) -
Drug-induced psoriasis: clinical perspectives
por: Balak, Deepak MW, et al.
Publicado: (2017) -
Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments
por: Atwan, A., et al.
Publicado: (2016) -
Fumaric acid ester‐induced T‐cell lymphopenia in the real‐life treatment of psoriasis
por: Dickel, H., et al.
Publicado: (2019)